{"title": "Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del)", "doi": "10.1101/2020.03.19.998179", "citation_id": "2020.03.19.998179v1", "date": "2020-03-21", "laguage": "en", "journal_title": "bioRxiv", "first_page": "2020.03.19.998179", "abstract": "<p>We present the first genetic characterization of a COVID-19 cluster in Europe using metagenomic next-generation sequencing (mNGS). Despite low viral loads, the mNGS workflow used herein allowed to characterize the whole genome sequences of SARS-CoV2 isolated from an asymptomatic patient, in 2 clinical samples collected 1 day apart. Comparison of these sequences suggests viral evolution with development of quasispecies. In addition, the present workflow identified a new deletion in nsp2 (Asp268Del) which was found in all 3 samples originating from this cluster as well as in 37 other viruses collected in England in February and in Netherlands in March, suggesting the spread of this deletion in Europe. The impact of Asp268Del on SARS-CoV-2 transmission and pathogenicity, as well as on PCR performances and anti-viral strategy should be rapidly evaluated in further studies.</p>", "twitter_description": "We present the first genetic characterization of a COVID-19 cluster in Europe using metagenomic next-generation sequencing (mNGS). Despite low viral loads, the mNGS workflow used herein allowed to characterize the whole genome sequences of SARS-CoV2 isolated from an asymptomatic patient, in 2 clinical samples collected 1 day apart. Comparison of these sequences suggests viral evolution with development of quasispecies. In addition, the present workflow identified a new deletion in nsp2 (Asp268Del) which was found in all 3 samples originating from this cluster as well as in 37 other viruses collected in England in February and in Netherlands in March, suggesting the spread of this deletion in Europe. The impact of Asp268Del on SARS-CoV-2 transmission and pathogenicity, as well as on PCR performances and anti-viral strategy should be rapidly evaluated in further studies.", "full_text_html_url": "https://www.biorxiv.org/content/10.1101/2020.03.19.998179v1.full", "public_url": "https://www.biorxiv.org/content/10.1101/2020.03.19.998179v1", "abstract_html_url": "https://www.biorxiv.org/content/10.1101/2020.03.19.998179v1.abstract", "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/03/21/2020.03.19.998179.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory", "pisa": "biorxiv;2020.03.19.998179v1", "access_rights": "restricted", "authors": ["Antonin Bal", "Gregory Destras", "Alexandre Gaymard", "Maude Bouscambert-Duchamp", "Martine Valette", "Vanessa Escuret", "Emilie Frobert", "Genevieve Billaud", "Sophie Trouillet-Assant", "Valerie Cheynet", "Karen Brengel-Pesce", "Florence Morfin", "Bruno Lina", "Laurence Josset"]}